290 related articles for article (PubMed ID: 18393011)
1. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
2. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
[No Abstract] [Full Text] [Related]
3. Update on duloxetine for the management of stress urinary incontinence.
Basu M; Duckett JR
Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
Zinner NR
Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
6. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
9. [A challenge].
Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
[No Abstract] [Full Text] [Related]
10. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
11. Mixed incontinence.
Wein AJ
J Urol; 2005 Jun; 173(6):2055-7. PubMed ID: 15879826
[No Abstract] [Full Text] [Related]
12. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
13. [Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence].
Krankenpfl J; 2005; 43(7-10):189-90. PubMed ID: 16515261
[No Abstract] [Full Text] [Related]
14. [Update on medical treatment of female stress urinary incontinence].
Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine for management of stress urinary incontinence.
Guay DR
Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
17. [Stress incontinence in general practice].
Krankenpfl J; 2004; 42(7-10):228-9. PubMed ID: 15675390
[No Abstract] [Full Text] [Related]
18. The use of Duloxetine in the treatment of male stress urinary incontinence.
Fink KG; Huber J; Würnschimmel E; Schmeller NT
Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
20. [The 10-minute consultation. Urinary incontinence in a woman].
Kolben M; Maurer S; Knitza R
MMW Fortschr Med; 2004 Jul; 146(29-30):59-60. PubMed ID: 15540565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
